ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000261105.1	Nilotinib	Chronic Lymphocytic Leukemia	0.035520088	Resistant
ENSG00000261105.1	Nilotinib	Breast invasive carcinoma	0.038357397	Sensitive